SoylentNews.org,
Pfizer, Moderna Vaccines Aren’t the Same; Study Finds Antibody…
Pfizer, Moderna Vaccines Aren’t the Same; Study Finds Antibody…
Original Article from The New England Journal of Medicine — Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Има хора, които не се страхуват да покажат на света, че са безкрайно глупави, но има и такива, които толкова много се срамуват от…
#UCE https://pubmed.ncbi.nlm.nih.gov/33301246/
*Medical data from vaccine use show Sinovac and Pfizer equally effective against Covid-19* There is very good published…
We’ve said it before and we’ll say it again, getting vaccinated, along with other simple mitigation strategies, is the best way…
We’ve said it before and we’ll say it again, getting vaccinated, along with other simple mitigation strategies, is the best way…
EMOttawa Journal…
Každý, kto chápe závažnosť Covid pandémie si vie predstaviť, ako by to vyzeralo, keby prvú vakcínu vyvinuli a schválili za…
Prof. Agnieszka Szuster-Ciesielska - wirusolog
*Medical data from vaccine use show Sinovac and Pfizer equally effective against Covid-19* There is very good published…
Hoje no Brasil há 4 tipos de vacinas administradas, sendo duas com registros definitivos (Pfizer e AstraZeneca e Jansen) e…
KNOW YOUR COVID-19 VACCINES! Data as of May 5…
Original Article from The New England Journal of Medicine — Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Posted @withregram • @dr.francisco_cardoso Depois do surgimento da pandemia da Covid-19, muitas dúvidas surgiram em relação às…
https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=WB
Según este análisis, dos dosis de la vacuna BNT162b2 dePfizer-BioNtech protege en un 95% contra Covid-19 en personas de 16 años…
Dos dosis de la vacuna BNT162b2 dePfizer-BioNtech protege en un 95% contra Covid-19 en personas de 16 años o más. Fuente: https…
Análisis de la vacuna Pfizer Biontech
On Friday, we discussed different COVID-19 vaccines, including 2 authorized in the U.S. and 1 authorized in the U.K., as well…
People often ask us what a person should expect during the timeline of their vaccination. We thought it best to address that…
La vacuna de ARN mensajero (biontech-pfizer) es segura y eficaz, con una protección de 95% contra el COVID-19 sintomático en…
People often ask us what a person should expect during the timeline of their vaccination. We thought it best to address that…
La vacuna de ARN mensajero (biontech-pfizer) es segura y eficaz, con una protección de 95% contra el COVID-19 sintomático en…
VACCINI A mRNA (Pfizer e Moderna) E VACCINI A VETTORI VIRALI (AstraZeneca e J
Copying this from a post by Andrea C. Love Ph.D. on LinkedIn. Sources for the data in the image are below. Unbiased Science…
💉GET VAXXED💉 Today I was fortunate enough to have my first COVID vaccination dose to help get this shit show under some…
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 and the BNT162b2 mRNA Covid-19 Vaccines
This week on #StraightToTheSource: How do we know the Covid-19 vaccine is safe and effective? To answer this question, we…
CONCLUSIONS A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older.
SZCZEPIMY SIĘ! Załączamy komentarz Janina Daily.
Vi er i skrivende stund oppe i 33 611 personer i Norge som har fått første dose av Comirnaty; covid-19-vaksinen utviklet av…
VACCINAZIONE ANTI-COVID Riprendiamo l’attività dopo la pausa natalizia con un post che esula dagli argomenti solitamente…
先週の抄読会 担当は永野先生でした。 とりあげた論文は、SARS-CoV-2に対するファイザー社・ビオンテッック社のmRNAワクチンについてのものです。 以下は永野先生のまとめ。 【論文選定理由】 SARS-CoV-2がパンデミックを起こしてから約1年が経…
Original Article from The New England Journal of Medicine — Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
And for completeness, the article on all of the details of the Pfizer vaccine, the first one given to health care providers in…
SARS-CoV-2: EMA macht Weg frei für zweiten mRNA-Impfstoff Deutsches Ärzteblatt vom Mittwoch, 6. Januar…
A new study was published in the New England Journal of Medicine called "Safety and Efficacy of the BNT162b2 mRNA Covid-19…
Точно на 31 декември бяха публикувани нови резултати от изпитванията на ваксината на Файзер/Бионтек, чрез които се правят заключе…
The Pfizer Covid19 vaccine Trial is published on NEJM today. It is very promising and it is a hope for us to go back to…
Disponible en Youtube: https://youtu.be/765cuzf7cf0 Referencias: 1. Consorcio global de la investigación quimosensorial: https…
DA LEGGERE PER CONOSCENZA: https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=featured_home
Hicimos un desglose de los componentes de la vacuna Pfizer-BioNTech, que tiene la aprobación por parte de la FDA, EMA y COFEPRIS.
Sicherheit und Wirksamkeit der BNT162b2 mRNA Covid-19 Impfung New England Journal 2020
Vaccine shows early protection 12 days after first dose.
『ファイザーの遺伝子ワクチンのまとめ』 米国のファイザーの新型コロナ遺伝子ワクチン接種開始後すぐに、イギリスに引き続きまたアナフィラキシーショックの症例が出ました(『US health worker has serious allergic…
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Innocuité et efficacité du vaccin BNT162b2 contre la COVID-19 (étude financée par BioNTech and Pfizer) | Lien vers l'article …
Original Article from The New England Journal of Medicine — Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
In a trial of the BNT162b2 vaccine, subjects received two doses of vaccine or placebo 21 days apart. In 36,523 subjects with no…
Vacuna vs Covid-19😷 95% de protección Falta menos, no bajemos la guardia www.nejm.org/doi/full/10.1056/NEJMoa2034577 #vacu…
Original Article from The New England Journal of Medicine — Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
https://www.nejm.org/doi/10.1056/NEJMoa2034577?url_ver=Z39.88-2003
For those of you looking into the COVID vaccine, check out this great article from The New England Journal of Medicine 💉 https…
A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a…
A VACINA SÓ FOI TESTADA EM PESSOAS SAUDÁVEIS!!! MENTIRA... No melhor pano cai a nódoa. As pessoas têm que aprender a estar…
#BNT162b2_mRNA_COVID19_Vaccine "Pfizer and BioNTech" #Efficacy ~ 1st Dose– 52%; 2nd Dose– 95% #Side_Effects ~Transient…
https://www.nejm.org/doi/full/10.1056/NEJMoa2034577
Infographic from The New England Journal of Medicine on the newly approved #COVID19 vaccine 👍 https://www.nejm.org/doi/full/10.1…
請大家逐字睇完。
Vacina COVID-19 e reações imunoalérgicas Posicionamento da Diretoria…
I find popular news sources less and less reliable and rather disgusting in their coverage. Here's the actual source on the…
As information becomes available on vaccines for COVID-19, we will continue to keep you informed. Safety and Efficacy of the…
In a trial of the BNT162b2 vaccine, participants received two doses of vaccine or placebo 21 days apart. In 36,523 subjects…
https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?source=nejmtwitter
https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=featured_home
Frisch veröffentlicht: Der BioNTech-Impfstoff BNT162b2 ist bei zweimaligem Impfen (Tag 0 und Tag 21) zu 95% wirksam. Die…
https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=featured_home
COVID19ワクチンフロントランナーBNT162b2が、43,548人のP3結果をNEJM発表。高齢者への有効性を確言。既感染者は除外した。薬物アレルギー既往者の除外は条件でなかったが、アナフィラキシーはなかった、と。追跡期間は半年:C4591001Gro…
And here's the published paper on the Pfizer vaccine. Hot off the press. Very impressive data. https://www.nejm.org/doi/full/10.1…
Just released. New England Journal of Medicine article on Pfizer vaccine. Tl:dr - 95% efficacy with a side effect profile…
Much awaited report released! https://www.nejm.org/doi/10.1056/NEJMoa2034577?fbclid=IwAR0qm2JXgubs48PxfTd0nheFFzKvxD7KuAP34bwzaA…
https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=RP
Pfizer's COVID19 vaccine data have been published, showing it is safe and effective.
In a trial of the BNT162b2 vaccine, subjects received two doses of vaccine or placebo 21 days apart. In 36,523 subjects with no…
先ほど米ファイザーと独ビオンテックの新型コロナワクチンの臨床試験のデータがNEJMに掲載されました。 https://www.nejm.org/doi/full/10.1056/NEJMoa2034577?query=RP
Gerade folgte auch die Veröffentlichung "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine" im NEJM - www.nejm.org/doi/fu…